| 000 | 01619 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515122121.0 | ||
| 264 | 0 | _c20080825 | |
| 008 | 200808s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2008.05.028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFortin, Jessica S | |
| 245 | 0 | 0 |
_aCycloalkyl-substituted aryl chloroethylureas inhibiting cell cycle progression in G0/G1 phase and thioredoxin-1 nuclear translocation. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cJun 2008 |
||
| 300 |
_a3526-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aActive Transport, Cell Nucleus _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aG1 Phase _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aResting Phase, Cell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 |
_aThioredoxins _xmetabolism |
| 650 | 0 | 4 |
_aUrea _xanalogs & derivatives |
| 700 | 1 | _aCôté, Marie-France | |
| 700 | 1 | _aLacroix, Jacques | |
| 700 | 1 | _aPatenaude, Alexandre | |
| 700 | 1 | _aPetitclerc, Eric | |
| 700 | 1 | _aC-Gaudreault, René | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 18 _gno. 12 _gp. 3526-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2008.05.028 _zAvailable from publisher's website |
| 999 |
_c17996191 _d17996191 |
||